Market Analysis and Insights: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market
The global Extracorporeal Membrane Oxygenation (ECMO) Machine market was valued at US$ 237.3 in 2020 and will reach US$ 275.1 million by the end of 2027, growing at a CAGR of 2.5% during 2022-2027.

Global Extracorporeal Membrane Oxygenation (ECMO) Machine Scope and Market Size
The global Extracorporeal Membrane Oxygenation (ECMO) Machine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Extracorporeal Membrane Oxygenation (ECMO) Machine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Venoarterial (VA)
Venovenous (VV)
Arteriovenous (AV)

Segment by Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)

The Extracorporeal Membrane Oxygenation (ECMO) Machine market is analysed and market size information is provided by regions (countries). Segment by Application, the Extracorporeal Membrane Oxygenation (ECMO) Machine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Getinge Group (Sweden)
Medtronic plc (Ireland)
LivaNova PLC (U.K.)
XENIOS AG (Germany)
Terumo Corporation (Japan)
MicroPort Scientific Corporation (China)
NIPRO Corporation (Japan)
OriGen Biomedical, Inc. (US)
ALung Technologies, Inc. (Germany)
EUROSETS S.r.l. (Italy)